세계의 얼굴용 주사제 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 최종 용도별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2024-2031년)

Global Facial Injectables Market size was valued at USD 10.1 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 28.01 billion by 2031, growing at a CAGR of 12.00% during the forecast period (2024-2031).

The global facial injectables market is set for substantial growth in the coming years, driven by an increasing demand for facial aesthetic enhancements. This sector encompasses the production, distribution, and application of injectable substances specifically designed for aesthetic treatments, primarily focusing on anti-aging solutions that reduce wrinkles, restore facial volume, and improve overall skin appearance. The market primarily revolves around two key methodologies: botulinum toxin injections and dermal fillers, both of which enhance skin glow and moisture retention, leading to improved texture. As consumer interest in facial cosmetics rises, coupled with a surge in disposable income among younger demographics, spending on beauty and cosmetic products is expected to see a positive uptick. Notably, the U.S. facial injectables market is anticipated to achieve a sustainable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the broader trend of increased consumer engagement with aesthetic treatments. The growing societal emphasis on appearance and self-care is further positioning the facial injectables market for continued expansion, making it a key area for investment and innovation within the beauty and wellness industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Facial Injectables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Facial Injectables Market Segmental Analysis

Global Facial Injectables Market is segmented by Product, Application, End-use and region. Based on component, the market is segmented into Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others. Based on Application, the market is segmented into Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Others. Based on End-use, the market is segmented into MedSpas, Dermatology Clinics, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Facial Injectables Market

The Global Facial Injectables market is poised for substantial growth, driven by the escalating consumer demand for non-invasive aesthetic solutions, particularly among the Millennial demographic, who increasingly favor facial injectables to address skin damage caused by environmental factors and lifestyle choices. With products like collagen fibers, hyaluronic acid fillers, and synthetic injectables, consumers are attracted to the dual benefits of hydration and UV protection, alongside minimal side effects. Additionally, rising disposable incomes and advancements in technology, which enhance safety by reducing infection risks and procedure costs, are further fueling the market's expansion during the forecast period.

Restraints in the Global Facial Injectables Market

The Global Facial Injectables market faces several market restraints that limit its expansion. Stringent regulatory requirements and limitations concerning product approval create barriers to entry and complicate the commercialization of new solutions. Additionally, skin-related side effects such as rashes and redness discourage potential consumers from seeking these treatments, especially as safety concerns grow. High costs associated with fillers can also deter patients from opting for facial injectables, while the lack of insurance coverage for aesthetic procedures further exacerbates the issue, restricting market growth. Together, these factors create a challenging environment for the advancement of the global facial injectables industry.

Market Trends of the Global Facial Injectables Market

The Global Facial Injectables market is witnessing a significant trend fueled by the rising acceptance of these cosmetic treatments among the male population. As more men seek anti-aging solutions, the adoption of dermal fillers and botulinum toxin is on the rise, reflecting a shift in societal norms around male aesthetics. Young males, in particular, are increasingly inclined towards tissue fillers for rejuvenation purposes, further driving this trend. Additionally, hyaluronic acid fillers are gaining traction due to their efficacy in anti-aging treatments, propelling market growth. This evolving landscape indicates a broader demographic embracing facial injectables, expanding the market's potential.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Facial Injectables Market by Product

• Market Overview
• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

Facial Injectables Market by Application

• Market Overview
• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

Facial Injectables Market by End-use

• Market Overview
• MedSpas
• Dermatology Clinics
• Hospitals

Facial Injectables Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Ispen (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz GmbH and Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinclair Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan Aesthetics (a subsidiary of AbbVie) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revanesse (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz North America (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesthetic Medical International Holdings Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neauvia (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments